Steven Cohen Abcam PLC Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$21.54 - $24.41 $142 Million - $161 Million	-6,603,976 Reduced 83.24%	1,330,000 $30.1 Million
Q2 2023 Aug 14, 2023	BUY	$12.62 - $24.47 $55.5 Million - $108 Million	4,394,379 Added 124.15%	7,933,976 $194 Million
Q1 2023 May 15, 2023	BUY	$12.98 - $17.1 $37.6 Million - $49.6 Million	2,898,772 Added 452.35%	3,539,597 $47.6 Million
Q4 2022 Feb 14, 2023	BUY	$13.92 - $17.0 $143,376 - $175,100	10,300 Added 1.63%	640,825 $9.97 Million
Q3 2022 Nov 14, 2022	BUY	$13.36 - $16.75 $8.42 Million - $10.6 Million	630,525 New	630,525 $9.45 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.